
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $1.7B | $1.5B | $2B | $3B | $3.1B | |
Revenue Growth (YoY) | -36.43% | -13.36% | 30.43% | 50.88% | 3.22% | |
Cost of Revenues | $1.3B | $1.2B | $1.6B | $2.5B | $2.4B | |
Gross Profit | $422.3M | $354.5M | $367.7M | $527.1M | $668.2M | |
Gross Profit Margin | 24.14% | 23.38% | 18.6% | 17.67% | 21.7% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $341.1M | $179M | $185.4M | $201.9M | $235.7M | |
Other Inc / (Exp) | -$394.8M | $71.1M | $153.3M | $89.3M | $62.8M | |
Operating Expenses | $341.1M | $179M | $185.4M | $201.9M | $235.7M | |
Operating Income | $81.2M | $175.5M | $182.3M | $325.2M | $432.5M | |
Net Interest Expenses | $211M | $191.4M | $209.1M | $265.5M | $273.5M | |
EBT. Incl. Unusual Items | -$524.6M | $55.2M | $126.5M | $149M | $221.8M | |
Earnings of Discontinued Ops. | $24.3M | $142.5M | -$26M | -$13.4M | -$14.3M | |
Income Tax Expense | -$274.1M | $15.9M | $27.6M | $9M | $50.4M | |
Net Income to Company | -$250.5M | $170.7M | $93.2M | $140M | $171.4M | |
Minority Interest in Earnings | $78.9M | $200K | -$12.8M | -$20.6M | -$18.7M | |
Net Income to Common Excl Extra Items | -$147.3M | $182M | $60.1M | $106M | $138.4M | |
Basic EPS (Cont. Ops) | -$1.27 | $1.79 | $0.73 | $1.31 | $1.69 | |
Diluted EPS (Cont. Ops) | -$1.27 | $1.75 | $0.71 | $1.27 | $1.64 | |
Weighted Average Basic Share | $115.9M | $101.5M | $81.9M | $81.2M | $81.9M | |
Weighted Average Diluted Share | $115.9M | $103.8M | $84.2M | $83.4M | $84.2M | |
EBITDA | -$55.1M | $512.3M | $612M | $707.7M | $789.1M | |
EBIT | -$313.6M | $246.6M | $335.6M | $414.5M | $495.3M | |
Revenue (Reported) | $1.7B | $1.5B | $2B | $3B | $3.1B | |
Operating Income (Reported) | $81.2M | $175.5M | $182.3M | $325.2M | $432.5M | |
Operating Income (Adjusted) | -$313.6M | $246.6M | $335.6M | $414.5M | $495.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $330.7M | $472.7M | $641.7M | $809.6M | $585.4M | |
Revenue Growth (YoY) | -46.25% | 42.94% | 35.75% | 26.17% | -27.69% | |
Cost of Revenues | $246.3M | $398.5M | $538.5M | $644.9M | $443.2M | |
Gross Profit | $84.4M | $74.2M | $103.2M | $164.7M | $142.2M | |
Gross Profit Margin | 25.52% | 15.7% | 16.08% | 20.34% | 24.29% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $44.7M | $44.7M | $49.9M | $52.3M | $50M | |
Other Inc / (Exp) | $10M | $26.9M | $13.3M | -$600K | $10.3M | |
Operating Expenses | $44.7M | $44.7M | $49.9M | $52.3M | $50M | |
Operating Income | $39.7M | $29.5M | $53.3M | $112.4M | $92.2M | |
Net Interest Expenses | $51.3M | $43.5M | $62.1M | $69.1M | $66.1M | |
EBT. Incl. Unusual Items | -$1M | $12.9M | $5.3M | $42.7M | $36.4M | |
Earnings of Discontinued Ops. | $6.3M | -$8M | -$3.1M | -$4.3M | -$1.9M | |
Income Tax Expense | $4M | $3M | -$11.5M | $11M | $7.4M | |
Net Income to Company | $1.3M | $1.9M | $13.7M | $27.4M | $27.1M | |
Minority Interest in Earnings | $2M | -$2.6M | -$9.3M | -$3.7M | -$5M | |
Net Income to Common Excl Extra Items | $3.3M | -$700K | $4.4M | $23.7M | $22.1M | |
Basic EPS (Cont. Ops) | $0.03 | -$0.01 | $0.05 | $0.29 | $0.27 | |
Diluted EPS (Cont. Ops) | $0.03 | -$0.01 | $0.05 | $0.28 | $0.26 | |
Weighted Average Basic Share | $110.2M | $82.9M | $80.8M | $81.6M | $81.6M | |
Weighted Average Diluted Share | $110.2M | $85.5M | $83.2M | $83.5M | $83.8M | |
EBITDA | $114.9M | $123.3M | $141.4M | $185.2M | $176.8M | |
EBIT | $50.3M | $56.4M | $67.4M | $111.8M | $102.5M | |
Revenue (Reported) | $330.7M | $472.7M | $641.7M | $809.6M | $585.4M | |
Operating Income (Reported) | $39.7M | $29.5M | $53.3M | $112.4M | $92.2M | |
Operating Income (Adjusted) | $50.3M | $56.4M | $67.4M | $111.8M | $102.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.5B | $1.7B | $2.1B | $3.2B | $2.9B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.1B | $1.3B | $1.7B | $2.6B | $2.2B | |
Gross Profit | $373.5M | $344.3M | $396.7M | $588.6M | $645.7M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $321.5M | $179M | $190.6M | $204.3M | $233.4M | |
Other Inc / (Exp) | -$384.7M | $87.4M | $139.7M | $74.6M | $73.7M | |
Operating Expenses | $321.5M | $179M | $190.6M | $204.3M | $233.4M | |
Operating Income | $52M | $165.3M | $206.1M | $384.3M | $412.3M | |
Net Interest Expenses | $208.4M | $183.6M | $227.7M | $272.5M | $270.5M | |
EBT. Incl. Unusual Items | -$540.5M | $69.1M | $118.9M | $186.4M | $215.5M | |
Earnings of Discontinued Ops. | $30.8M | $128.2M | -$21.1M | -$14.6M | -$11.9M | |
Income Tax Expense | -$122.5M | $14.9M | $13.1M | $31.5M | $46.8M | |
Net Income to Company | -$411.7M | $171.3M | $105M | $153.7M | $171.1M | |
Minority Interest in Earnings | $81.5M | -$4.4M | -$19.5M | -$15M | -$20M | |
Net Income to Common Excl Extra Items | -$305.7M | $178M | $65.2M | $125.3M | $136.8M | |
Basic EPS (Cont. Ops) | -$2.65 | $1.83 | $0.80 | $1.54 | $1.66 | |
Diluted EPS (Cont. Ops) | -$2.65 | $1.81 | $0.78 | $1.49 | $1.62 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$75.9M | $520.7M | $630.1M | $751.5M | $780.7M | |
EBIT | -$332.1M | $252.7M | $346.6M | $458.9M | $486M | |
Revenue (Reported) | $1.5B | $1.7B | $2.1B | $3.2B | $2.9B | |
Operating Income (Reported) | $52M | $165.3M | $206.1M | $384.3M | $412.3M | |
Operating Income (Adjusted) | -$332.1M | $252.7M | $346.6M | $458.9M | $486M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $330.7M | $472.7M | $641.7M | $809.6M | $585.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $246.3M | $398.5M | $538.5M | $644.9M | $443.2M | |
Gross Profit | $84.4M | $74.2M | $103.2M | $164.7M | $142.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $44.7M | $44.7M | $49.9M | $52.3M | $50M | |
Other Inc / (Exp) | $10M | $26.9M | $13.3M | -$600K | $10.3M | |
Operating Expenses | $44.7M | $44.7M | $49.9M | $52.3M | $50M | |
Operating Income | $39.7M | $29.5M | $53.3M | $112.4M | $92.2M | |
Net Interest Expenses | $51.3M | $43.5M | $62.1M | $69.1M | $66.1M | |
EBT. Incl. Unusual Items | -$1M | $12.9M | $5.3M | $42.7M | $36.4M | |
Earnings of Discontinued Ops. | $6.3M | -$8M | -$3.1M | -$4.3M | -$1.9M | |
Income Tax Expense | $4M | $3M | -$11.5M | $11M | $7.4M | |
Net Income to Company | $1.3M | $1.9M | $13.7M | $27.4M | $27.1M | |
Minority Interest in Earnings | $2M | -$2.6M | -$9.3M | -$3.7M | -$5M | |
Net Income to Common Excl Extra Items | $3.3M | -$700K | $4.4M | $23.7M | $22.1M | |
Basic EPS (Cont. Ops) | $0.03 | -$0.01 | $0.05 | $0.29 | $0.27 | |
Diluted EPS (Cont. Ops) | $0.03 | -$0.01 | $0.05 | $0.28 | $0.26 | |
Weighted Average Basic Share | $110.2M | $82.9M | $80.8M | $81.6M | $81.6M | |
Weighted Average Diluted Share | $110.2M | $85.5M | $83.2M | $83.5M | $83.8M | |
EBITDA | $114.9M | $123.3M | $141.4M | $185.2M | $176.8M | |
EBIT | $50.3M | $56.4M | $67.4M | $111.8M | $102.5M | |
Revenue (Reported) | $330.7M | $472.7M | $641.7M | $809.6M | $585.4M | |
Operating Income (Reported) | $39.7M | $29.5M | $53.3M | $112.4M | $92.2M | |
Operating Income (Adjusted) | $50.3M | $56.4M | $67.4M | $111.8M | $102.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $132M | $167.3M | $79.6M | $105.7M | $228.2M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $164.4M | $227.6M | $323.5M | $363.5M | $379.1M | |
Inventory | $285.2M | $432.9M | $629.4M | $684.3M | $476.2M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $1.3B | $968.3M | $1.3B | $1.3B | $1.2B | |
Property Plant And Equipment | $7B | $6.8B | $6.9B | $7B | $7B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $147.2M | $154.2M | $195.9M | $221.5M | $221.5M | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $283.5M | $266.5M | $386.6M | $392.1M | $390.5M | |
Total Assets | $8.7B | $8.2B | $8.7B | $8.9B | $8.8B | |
Accounts Payable | $146.1M | $206.4M | $287.5M | $305.3M | $251.7M | |
Accrued Expenses | $310M | $307.4M | $261M | $302.3M | $353M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $456.1M | $513.8M | $548.5M | $607.6M | $604.7M | |
Long-Term Debt | $5B | $5.2B | $5.6B | $5.8B | $5.7B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $6.7B | $6.9B | $7.5B | $7.6B | $7.5B | |
Common Stock | $1.1M | $800K | $800K | $800K | $800K | |
Other Common Equity Adj | -$30.9M | -$17M | $19.7M | $11M | -$4.2M | |
Common Equity | $1.7B | $1B | $1B | $1B | $1.1B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $277.2M | $267M | $257.2M | $238.4M | $248.3M | |
Total Equity | $2B | $1.3B | $1.3B | $1.3B | $1.3B | |
Total Liabilities and Equity | $8.7B | $8.2B | $8.7B | $8.9B | $8.8B | |
Cash and Short Terms | $132M | $167.3M | $79.6M | $105.7M | $228.2M | |
Total Debt | $5B | $5.2B | $5.6B | $5.8B | $5.7B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $178.1M | $143.2M | $81.9M | $118.8M | $94.9M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $197.3M | $190.1M | $333.2M | $484M | $368.9M | |
Inventory | $320.9M | $508.4M | $632.7M | $643.1M | $449.7M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $1.2B | $1.1B | $1.2B | $1.4B | $1.1B | |
Property Plant And Equipment | $7B | $6.8B | $7.1B | $7.1B | $7B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $215.7M | $154.2M | $222.3M | $221.5M | $221.5M | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $288.8M | $278.8M | $310.2M | $431.6M | $371.6M | |
Total Assets | $8.8B | $8.3B | $8.8B | $9.1B | $8.7B | |
Accounts Payable | $159.2M | $237.5M | $314.5M | $335.9M | $255.4M | |
Accrued Expenses | $276.3M | $271.3M | $273.7M | $328.3M | $281.9M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $435.5M | $508.8M | $588.2M | $664.2M | $537.3M | |
Long-Term Debt | $5.2B | $5.2B | $5.7B | $5.9B | $5.6B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $6.8B | $7B | $7.6B | $7.8B | $7.4B | |
Common Stock | $1.1M | $800K | $800K | $800K | $800K | |
Other Common Equity Adj | -$25.8M | $100K | $12.7M | $18.4M | -$4.2M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $275.5M | $263.6M | $256.2M | $239.2M | $246.5M | |
Total Equity | $2B | $1.3B | $1.3B | $1.3B | $1.3B | |
Total Liabilities and Equity | $8.8B | $8.3B | $8.8B | $9.1B | $8.7B | |
Cash and Short Terms | $178.1M | $143.2M | $81.9M | $118.8M | $94.9M | |
Total Debt | $5.2B | $5.2B | $5.7B | $5.9B | $5.6B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$250.5M | $170.7M | $93.2M | $140M | $171.4M | |
Depreciation & Amoritzation | $258.5M | $265.7M | $276.4M | $293.2M | $293.8M | |
Stock-Based Compensation | $25.4M | $20.7M | $22.5M | $22.7M | $23.6M | |
Change in Accounts Receivable | -$379.9M | $376.1M | -$94.4M | -$22M | -$14.3M | |
Change in Inventories | $106.4M | -$147.7M | -$193.4M | -$54.9M | $208.1M | |
Cash From Operations | $651.7M | $611.8M | -$12.8M | $295.6M | $573.8M | |
Capital Expenditures | $698.1M | $570.8M | $966.8M | $710.1M | $595.7M | |
Cash Acquisitions | -- | -$16.5M | -$95.9M | -$63.3M | -$3.9M | |
Cash From Investing | -$532.9M | $276.3M | -$260.7M | -$363M | -$214.6M | |
Dividends Paid (Ex Special Dividend) | -$91.7M | -$88.5M | -$76.9M | -$86M | -$93.2M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $1.6B | $2.4B | $2B | $1.7B | $2B | |
Long-Term Debt Repaid | -$1.4B | -$2.3B | -$1.6B | -$1.5B | -$2.1B | |
Repurchase of Common Stock | -$200.8M | -$842.7M | -$57.5M | -$7.2M | -$29.7M | |
Other Financing Activities | $6M | -$11.2M | -$22.3M | -$32.4M | -$16.9M | |
Cash From Financing | -$168M | -$814.1M | $265.4M | $8.2M | -$219.9M | |
Beginning Cash (CF) | $277.6M | $228.4M | $302.4M | $294.3M | $235.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$49.2M | $74M | -$8.1M | -$59.2M | $139.3M | |
Ending Cash (CF) | $228.4M | $302.4M | $294.3M | $235.1M | $374.4M | |
Levered Free Cash Flow | -$46.4M | $41M | -$979.6M | -$414.5M | -$21.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $1.3M | $1.9M | $13.7M | $27.4M | $27.1M | |
Depreciation & Amoritzation | $64.6M | $66.9M | $74M | $73.4M | $74.3M | |
Stock-Based Compensation | $5.1M | $5.1M | $6.2M | $4.7M | $5.3M | |
Change in Accounts Receivable | $13.3M | $38.2M | $2.8M | -$118.1M | $10.1M | |
Change in Inventories | $8.7M | -$75.5M | -$3.3M | $41.2M | $26.5M | |
Cash From Operations | $69.7M | $20.5M | $99.4M | $52.2M | $76.5M | |
Capital Expenditures | $115.3M | $86.9M | $198.6M | $152.1M | $129.4M | |
Cash Acquisitions | -$16.6M | -- | -$67.3M | -- | -- | |
Cash From Investing | -$96M | -$200K | -$203.1M | -$124M | -$91.6M | |
Dividends Paid (Ex Special Dividend) | -$23.2M | -$19.1M | -$21.1M | -$23M | -$24.6M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $327.7M | $127.2M | $246.3M | $909.9M | -- | |
Long-Term Debt Repaid | -$185.3M | -$73M | -$149.6M | -$803.8M | -$77.3M | |
Repurchase of Common Stock | -$35.8M | -$200K | -$300K | -$300K | -$8.5M | |
Other Financing Activities | -- | -$6.2M | -$2.9M | -$11M | -$13.8M | |
Cash From Financing | $83.4M | $28.7M | $72.4M | $71.8M | -$124.2M | |
Beginning Cash (CF) | $228.4M | $302.4M | $294.3M | $235.1M | $374.4M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $57.1M | $49M | -$31.3M | -- | -$139.3M | |
Ending Cash (CF) | $285.5M | $351.4M | $263M | $235.1M | $235.1M | |
Levered Free Cash Flow | -$45.6M | -$66.4M | -$99.2M | -$99.9M | -$52.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$411.7M | $171.3M | $105M | $153.7M | $171.1M | |
Depreciation & Amoritzation | $256.2M | $268M | $283.5M | $292.6M | $294.7M | |
Stock-Based Compensation | $23.2M | $20.7M | $23.6M | $21.2M | $24.2M | |
Change in Accounts Receivable | $45.6M | $401M | -$129.8M | -$142.9M | $113.9M | |
Change in Inventories | $123.7M | -$231.9M | -$121.2M | -$10.4M | $193.4M | |
Cash From Operations | $547.8M | $562.6M | $66.1M | $248.4M | $598.1M | |
Capital Expenditures | $670.2M | $542.4M | $1.1B | $663.6M | $573M | |
Cash Acquisitions | -$16.6M | $100K | -$163.2M | $4M | -$3.9M | |
Cash From Investing | -$564.3M | $372.1M | -$463.6M | -$283.9M | -$182.2M | |
Dividends Paid (Ex Special Dividend) | -$92.2M | -$84.4M | -$78.9M | -$87.9M | -$94.8M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $1.4B | $2.2B | $2.1B | $2.3B | $1.1B | |
Long-Term Debt Repaid | -$1.2B | -$2.2B | -$1.7B | -$2.2B | -$1.3B | |
Repurchase of Common Stock | -$201.2M | -$807.1M | -$57.6M | -$7.2M | -$37.9M | |
Other Financing Activities | -- | -- | -$19M | -$40.5M | -$19.7M | |
Cash From Financing | -$7.5M | -$868.8M | $309.1M | $7.6M | -$415.9M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$24M | $65.9M | -$88.4M | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$122.4M | $20.2M | -$1B | -$415.2M | $25.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $1.3M | $1.9M | $13.7M | $27.4M | $27.1M | |
Depreciation & Amoritzation | $64.6M | $66.9M | $74M | $73.4M | $74.3M | |
Stock-Based Compensation | $5.1M | $5.1M | $6.2M | $4.7M | $5.3M | |
Change in Accounts Receivable | $13.3M | $38.2M | $2.8M | -$118.1M | $10.1M | |
Change in Inventories | $8.7M | -$75.5M | -$3.3M | $41.2M | $26.5M | |
Cash From Operations | $69.7M | $20.5M | $99.4M | $52.2M | $76.5M | |
Capital Expenditures | $115.3M | $86.9M | $198.6M | $152.1M | $129.4M | |
Cash Acquisitions | -$16.6M | -- | -$67.3M | -- | -- | |
Cash From Investing | -$96M | -$200K | -$203.1M | -$124M | -$91.6M | |
Dividends Paid (Ex Special Dividend) | -$23.2M | -$19.1M | -$21.1M | -$23M | -$24.6M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $327.7M | $127.2M | $246.3M | $909.9M | -- | |
Long-Term Debt Repaid | -$185.3M | -$73M | -$149.6M | -$803.8M | -$77.3M | |
Repurchase of Common Stock | -$35.8M | -$200K | -$300K | -$300K | -$8.5M | |
Other Financing Activities | -- | -$6.2M | -$2.9M | -$11M | -$13.8M | |
Cash From Financing | $83.4M | $28.7M | $72.4M | $71.8M | -$124.2M | |
Beginning Cash (CF) | $228.4M | $302.4M | $294.3M | $235.1M | $374.4M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $57.1M | $49M | -$31.3M | -- | -$139.3M | |
Ending Cash (CF) | $285.5M | $351.4M | $263M | $235.1M | $235.1M | |
Levered Free Cash Flow | -$45.6M | -$66.4M | -$99.2M | -$99.9M | -$52.9M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.